Yann Mazabraud
Corporate Officer/Principal bij RHYTHM PHARMACEUTICALS, INC.
Vermogen: 1 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Yann Mazabraud
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 23 | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
17
| Subsidiary | Medical Specialties | 17 |
Public Company | Biotechnology | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Yann Mazabraud via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Massachusetts Institute of Technology | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal General Counsel Director/Board Member Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Founder Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
TURMERIC ACQUISITION CORP. | Financial Conglomerates | President Director/Board Member | |
SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
Temple University (Pennsylvania) | College/University | Undergraduate Degree Graduate Degree | |
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Dartmouth College | College/University | Doctorate Degree Undergraduate Degree | |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Director/Board Member | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Founder Private Equity Analyst | |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer General Counsel | |
University of Virginia | College/University | Graduate Degree Undergraduate Degree | |
UMass Chan Medical School | College/University | Doctorate Degree Doctorate Degree | |
ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Operating Officer General Counsel | |
Columbia Law School | College/University | Graduate Degree Graduate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel | |
The University of Edinburgh | College/University | Doctorate Degree Corporate Officer/Principal | |
VERICEL CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
IMMUNOGEN, INC. | Biotechnology | Director/Board Member Director/Board Member | |
JCR PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
ALAUNOS THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Doctorate Degree | |
Tarrant Capital IP LLC
Tarrant Capital IP LLC Investment ManagersFinance Tarrant Capital IP LLC operates as a venture capital firm. It serves the consumer, retail, technology, internet, healthcare, energy, cleantech, digital media, real estate, renewables and transportation industries. The company was founded by David Bonderman and Jim Coulter in 1992 and is headquartered in San Francisco, CA. | Investment Managers | Corporate Officer/Principal | |
MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Israel Defense Forces | Sovereign | Corporate Officer/Principal | |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Corporate Officer/Principal | |
Stanford University School of Medicine | College/University | Undergraduate Degree | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 39 |
Frankrijk | 4 |
Verenigd Koninkrijk | 4 |
Zwitserland | 3 |
Israël | 3 |
Sectoraal
Health Technology | 29 |
Consumer Services | 14 |
Finance | 6 |
Commercial Services | 4 |
Government | 2 |
Operationeel
Director/Board Member | 240 |
Corporate Officer/Principal | 105 |
Independent Dir/Board Member | 81 |
Undergraduate Degree | 39 |
Chief Tech/Sci/R&D Officer | 32 |
Sterkste connecties
Insiders | |
---|---|
Ed Mathers Mathers | 47 |
Todd Foley | 38 |
Otello Stampacchia | 37 |
Mette Agger | 30 |
Anne VanLent | 23 |
Eran Nadav | 21 |
Christophe Jean | 19 |
David Meeker | 19 |
Camille Bedrosian | 18 |
Irina Antonijevic | 17 |
Richard Peters | 16 |
David McGirr | 16 |
Lynn Tetrault | 15 |
Stuart Arbuckle | 10 |
John Koconis | 10 |
- Beurs
- Insiders
- Yann Mazabraud
- Bedrijfsconnecties